![Thierry Chauche](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thierry Chauche
Finanzdirektor/CFO bei
SAGIMET BIOSCIENCES INC.
Vermögen: 160 959 $ am 31.08.2026
Profil
Thierry Chauche is currently Chief Financial & Accounting Officer at Sagimet Biosciences, Inc. since 2024.
Formerly, Mr. Chauche was Chief Financial Officer at Provention Bio, Inc. from 2021 to 2023 and VP, Head-Strategic Financial Planning & Analysis at Alexion Pharmaceuticals, Inc. from 2020 to 2021.
Education includes an MBA from The Wharton School of the University of Pennsylvania and a graduate degree from école Des Ponts Paristec.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.05.2026 | 15.688 ( 0,03 % ) | 160 959 $ | 31.08.2026 |
Aktive Positionen von Thierry Chauche
| Unternehmen | Position | Beginn |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Finanzdirektor/CFO | 06.05.2024 |
Ehemalige bekannte Positionen von Thierry Chauche
| Unternehmen | Position | Ende |
|---|---|---|
| PROVENTION BIO, INC. | Finanzdirektor/CFO | 01.04.2023 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.01.2021 |
Ausbildung von Thierry Chauche
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
35
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
école Des Ponts Paristec
 école Des Ponts Paristec Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
